0141 352 98 55

25 Blythswood Square, Glasgow, G2 4BL

Engaging with patients with health conditions that put them at high risk of getting seriously unwell from COVID-19
March 24, 2020

COVID-19 is a new illness that can affect your lungs and airways and is caused by a virus called coronavirus.

Everyone is at risk of getting COVID-19, however, certain individuals are more likely to become seriously unwell if they contract it. These people are categorised as being “high risk” and have been asked to stay at home and completely self-isolate to protect themselves from the virus. This high risk segment of society covers a large proportion of the population; the elderly, pregnant women and those who suffer from certain medical conditions such as diabetes and asthma.

Evidently for those with these health conditions, there has never been a more important time to take medicines correctly. Ensuring that these individuals take their meds properly is of the utmost importance if we are to minimise hospital admissions and spread of disease.

Though we are incredibly lucky to have the NHS to help us with this, we must all play a conscious role in alleviating pressure from this lifesaving service where possible and should be using the resources we have at home to manage our health. We now have access to skype appointments, online prescription renewals, digital health forums and can even track our medicines, exercise and general health online using apps. This access to healthcare resources and information is an asset, one which has real potential to help us all through these difficult times.

Using our Medsmart® tool we can determine patient personas across different therapeutic areas and uncover the true patient voice behind specific medications. We also have the capability to push out educational content and engage with cohorts to help ensure patients are taking their medications as intended.

If you’re interested in finding out more about our patient insights and how we can help you engage with patients during these unprecedented times, please get in touch! Together we can beat coronavirus.

 

 

 

 

Recent Blogs

Appointment of Head of Data Quality

Appointment of Head of Data Quality

Data insights firm Talking Medicines, specialist in ‘social intelligence’ for the pharmaceutical industry, has appointed Donna Lawson to the position of Head of Data Quality. A particularly good fit for the role, Donna brings with her over two decades’ experience...

The effect of self-diagnosis on patient outcomes

The effect of self-diagnosis on patient outcomes

The internet is a wonderful place. You can find photos of places you want to visit, maps of your favourite mountain ranges, tutorials on how to bake the perfect birthday cake…the list goes on. In recent years, however, there has been a marked increase in the number of...

Pharma Business International Interview

Pharma Business International Interview

Pharma Business International spoke with Jo Halliday, CEO of Talking Medicines, the world’s first social intelligence company designed specifically for the pharmaceutical industry.  The full article can be found here on page 10-11 Tell us about Talking Medicines?...

Tracking Covid vaccine progress through Medsmart®

Tracking Covid vaccine progress through Medsmart®

In the race against new super spreading virus variants, the UK among other countries have implemented a fast streamed vaccine programme to protect the vulnerable as quickly as possible. Since the beginning of January, 17,916,181 people in the UK have been given their...